The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
An Insertion Mutation of the CHRNA4 Gene in a Family With Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
Abstract
Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is the first, and to date only, idiopathic epilepsy for which a specific mutation has been found. A missense mutation in the critical M2 domain of the alpha4 subunit of the neuronal nicotinic acetylcholine receptor (CHRNA4) has been recently identified in one large Australian pedigree. Here we describe a novel mutation in the M2 domain of the CHRNA4 gene in a Norwegian family. Three nucleotides (GCT) were inserted at nucleotide position 776 into the coding region for the C-terminal end of the M2 domain. Physiological investigations of the receptor reconstituted with the mutated CHRNA4 subunit reveal that this insertion does not prevent the receptor function but increases its apparent affinity for ACh. In addition, this mutant receptor shows a significantly lower calcium permeability that, at the cellular level, may correspond to a loss of function. Comparison of the two mutations identified so far in families with ADNFLE illustrates that different mutations can result in similar phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
Steinlein, O. K., Mulley, J. C., Propping, P., Wallace, R. H., Phillips, H. A., Sutherland, G. R., Scheffer, I. E., & Berkovic, S. F. (1995) · Nature Genetics · doi:10.1038/ng1095-201 · Cited by 1,134
Self-citationHippocampal synaptic transmission enhanced by low concentrations of nicotine
Gray, R., Rajan, A. S., Radcliffe, K. A., Yakehiro, M., & Dani, J. A. (1996) · Nature · doi:10.1038/383713a0 · Cited by 947
Noda, M., Takahashi, H., Tanabe, T., Toyosato, M., Furutani, Y., Hirose, T., Asai, M., Inayama, S., Miyata, T., & Numa, S. (1982) · Nature · doi:10.1038/299793a0 · Cited by 735
Isolation of a novel gene underlying batten disease, CLN3
Lerner, T. J., Boustany, R.-M. N., Anderson, J. W., D'Arigo, K. L., Schlumpf, K., Buckler, A. J., Gusella, J. F., & Haines, J. L. (1995) · Cell · doi:10.1016/0092-8674(95)90274-0 · Cited by 601
Wallace, D. C., Zheng, X., Lott, M. T., Shoffner, J. M., Hodge, J. A., Kelley, R. I., Epstein, C. M., & Hopkins, L. C. (1988) · Cell · doi:10.1016/0092-8674(88)90218-8 · Cited by 542
Mutations in the Gene Encoding Cystatin B in Progressive Myoclonus Epilepsy (EPM1)
Pennacchio, L. A., Lehesjoki, A.-E., Stone, N. E., Willour, V. L., Virtaneva, K., Miao, J., D'Amato, E., Ramirez, L., Faham, M., Koskiniemi, M., et al. (1996) · Science · doi:10.1126/science.271.5256.1731 · Cited by 541
Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor
Revah, F., Bertrand, D., Galzi, J.-L., Devillers-Thiéry, A., Mulle, C., Hussy, N., Bertrand, S., Ballivet, M., & Changeux, J.-P. (1991) · Nature · doi:10.1038/353846a0 · Cited by 525
Self-citationAutosomal dominant nocturnal frontal lobe epilepsy: A distinctive clinical disorder
Scheffer, I. E., Bhatia, K. P., Lopes-Cendes, I., Fish, D. R., Marsden, C. D., Andermann, E., Andermann, F., Desbiens, R., Keene, D., Cendes, F., et al. (1995) · Brain · doi:10.1093/brain/118.1.61 · Cited by 503
Self-citationBertrand, D., Galzi, J. L., Devillers-Thiéry, A., Bertrand, S., & Changeux, J. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.6971 · Cited by 391
Self-citationLocalization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q13.2
Phillips, H. A., Scheffer, I. E., Berkovic, S. F., Hollway, G. E., Sutherland, G. R., & Mulley, J. C. (1995) · Nature Genetics · doi:10.1038/ng0595-117 · Cited by 321
Self-citationAutosomal dominant frontal epilepsy misdiagnosed as sleep disorder
SCHEFFER, I. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91463-x · Cited by 318
Deneris, E. S., Connolly, J., Boulter, J., Wada, E., Wada, K., Swanson, L. W., Patrick, J., & Heinemann, S. (1988) · Neuron · doi:10.1016/0896-6273(88)90208-5 · Cited by 297
Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain.
Bertrand, D., Devillers-Thiéry, A., Revah, F., Galzi, J. L., Hussy, N., Mulle, C., Bertrand, S., Ballivet, M., & Changeux, J. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1261 · Cited by 240
Self-citationPeng, X., Katz, M., Gerzanich, V, Anand, R., & Lindstrom, J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10029-1 · Cited by 222
Role of Ca2+Ions in Nicotinic Facilitation of GABA Release in Mouse Thalamus
Léna, C., & Changeux, J.-P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00576.1997 · Cited by 220
Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptor
Gopalakrishnan, M., Buisson, B., Touma, E., Giordano, T., Campbell, J. E., Hu, I. C., Donnelly-Roberts, D., Arneric, S. P., Bertrand, D., & Sullivan, J. P. (1995) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(95)00083-6 · Cited by 172
Self-citationHuman α4β2 Neuronal Nicotinic Acetylcholine Receptor in HEK 293 Cells: A Patch-Clamp Study
Buisson, B., Gopalakrishnan, M., Arneric, S. P., Sullivan, J. P., & Bertrand, D. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-24-07880.1996 · Cited by 161
Self-citationBertrand, D., Ballivet, M., & Rungger, D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1993 · Cited by 158
Self-citationWeiland, S., Witzemann, V., Villarroel, A., Propping, P., & Steinlein, O. K. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01215-x · Cited by 155
Self-citationBallivet, M., Nef, P., Couturier, S., Rungger, D., Bader, C. R., Bertrand, D., & Cooper, E. A. (1988) · Neuron · doi:10.1016/0896-6273(88)90132-8 · Cited by 129
Self-citationAutosomal Dominant Nocturnal Frontal Lobe Epilepsy: Electroclinical Picture
Oldani, A., Zucconi, M., Ferini‐Strambi, L., Bizzozero, D., & Smirne, S. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb00534.x · Cited by 128
Bertrand, D., Cooper, E. A., Valera, S., Rungger, D., & Ballivet, M. (1991) · Methods in neurosciences · doi:10.1016/b978-0-12-185257-3.50017-3 · Cited by 91
Self-citationMcGehee, D. S., & Role, L. W. (1996) · Nature · doi:10.1038/383670a0 · Cited by 36
Autosomal dominant frontal epilepsy
Magnússon, A., Nakken, K. O., & Brubakk, E. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90652-2 · Cited by 19
Self-citation
Cited by
Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System
Dani, J. A., & Bertrand, D. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105214 · Cited by 1,197
Self-citationA Potassium Channel Mutation in Neonatal Human Epilepsy
Biervert, C., Schroeder, B. C., Kubisch, C., Berkovic, S. F., Propping, P., Jentsch, T. J., & Steinlein, O. K. (1998) · Science · doi:10.1126/science.279.5349.403 · Cited by 1,073
Self-citationWallace, R. H., Wang, D. W., Singh, R., Scheffer, I. E., George, A. L., Phillips, H. A., Saar, K., Reis, A., Johnson, E. W., Sutherland, G. R., et al. (1998) · Nature Genetics · doi:10.1038/1252 · Cited by 996
Self-citationNeuronal nicotinic receptors: from structure to pathology
Gotti, C., & Clementi, F. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.006 · Cited by 970
Nicotinic Receptors at the Amino Acid Level
Corringer, P.-J., Novère, N. L., & Changeux, J.-P. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.431 · Cited by 820
Metadata
- Authors
- Steinlein, O. K., Magnusson, A., Stoodt, J., Bertrand, S., Weiland, S., Berkovic, S. F., Nakken, K. O., Propping, P., & Bertrand, D.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-06-01
- Volume
- 6
- Issue
- 6
- Pages
- 943-947
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2157955296
- Cited by
- 357
- References
- 25
- FWCI
- 31.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.